Related Experiment Video
Updated: Apr 29, 2026

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures
Published on: March 27, 2019
Revealing transcription factors during human pancreatic β cell development
Elizabeth Conrad1, Roland Stein1, Chad S Hunter1
1Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, 2215 Garland Ave, Nashville, TN 37232, USA.
Abstract:
Developing cell-based diabetes therapies requires examining transcriptional mechanisms underlying human β cell development. However, increased knowledge is hampered by low availability of fetal pancreatic tissue and gene targeting strategies. Rodent models have elucidated transcription factor roles during islet organogenesis and maturation, but differences between mouse and human islets have been identified. The past 5 years have seen strides toward generating human β cell lines, the examination of human transcription factor expression, and studies utilizing induced pluripotent stem cells (iPS cells) and human embryonic stem (hES) cells to generate β-like cells. Nevertheless, much remains to be resolved. We present current knowledge of developing human β cell transcription factor expression, as compared to rodents. We also discuss recent studies employing transcription factor or epigenetic modulation to generate β cells.
Insights
Understanding human beta cell development is key for diabetes therapies. This study compares human and rodent transcription factors, highlighting progress and challenges in generating beta cells from stem cells.
Area of Science:
- Endocrinology
- Developmental Biology
- Stem Cell Biology
Background:
- Cell-based therapies for diabetes necessitate understanding human beta cell development.
- Limited fetal tissue and gene targeting hinder research.
- Rodent models offer insights but differ from human islets.
Purpose of the Study:
- To review current knowledge of human beta cell transcription factor expression during development.
- To compare human and rodent transcription factor profiles.
- To discuss recent advancements in generating human beta-like cells.
Main Methods:
- Comparative analysis of transcription factor expression in human and rodent islets.
- Review of studies using human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells.
- Examination of transcription factor and epigenetic modulation strategies.
Main Results:
- Significant progress in generating human beta-like cells from stem cells.
- Identified differences in transcription factor roles between mouse and human islet development.
- Advances in using transcription factor or epigenetic modulation for beta cell generation.
Conclusions:
- Human beta cell development research is advancing, particularly with stem cell technologies.
- Further research is needed to fully elucidate human-specific transcriptional mechanisms.
- Transcription factor and epigenetic modulation show promise for future diabetes therapies.
Related Concept Videos
General Transcription Factors
Cell Specific Gene Expression
Transcription Factors
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Master Transcription Regulators
Type I Diabetes II: Pathophysiology

